Company profile: Adare Pharma Solutions
1.1 - Company Overview
Company description
- Provider of global technology-driven CDMO services spanning research, business and product development, formulation development (taste masking, customized release, patient-centered dosage forms), analytical services, clinical trial materials manufacturing and packaging (GMP and Non-GMP), commercial manufacturing, packaging, and logistical support, with delivery technologies including Diffucaps®, Microcaps®, and Optimμm®.
Products and services
- Analytical Services: Performs comprehensive analytical testing and stability studies across different temperature ranges, delivering laboratory-grade characterization data to support development and commercial manufacturing decisions
- Diffucaps: Engineers controlled-release components that optimize drug delivery and release profiles, offered in capsules and orally disintegrating tablets as a modular, controlled-release technology
- Formulation Development: Develops patient-centered dosage forms with taste masking and customized drug release, integrating targeted delivery profiles via a custom-engineered process for specific therapeutic requirements
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Adare Pharma Solutions
Elligo Health Research
HQ: United States
Website
- Description: Provider of clinical research solutions that bring research to physician practices to accelerate the development of medical devices and therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elligo Health Research company profile →
Lightship
HQ: United States
Website
- Description: Provider of services and solutions that make clinical trials more accessible for patients and providers to accelerate development of better therapies. Focused on improving health equity globally by offering studies that are more accessible and provide choice. Founded in 2018, it keeps people at the heart of its work and uses the latest innovations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lightship company profile →
Evotec
HQ: Germany
Website
- Description: Provider of drug discovery and gene therapy solutions, delivering CRO/CDMO services from initial research to clinical trials; AI-powered PanOmics and iPSC technologies for disease understanding in small molecules and biotherapeutics; hit identification; J.POD continuous biomanufacturing for biologics; and a proprietary ion channel assay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evotec company profile →
Corgenix
HQ: United States
Website
- Description: Provider of in vitro diagnostic products, including ELISA tests and vascular disease assays (antiphospholipid antibody), engaged in research, development, manufacturing, and marketing in North America and internationally. Offers contract development, GMP/FDA-registered manufacturing, CAP/CLIA lab testing, quality and regulatory (ISO13485, FDA) services, and clinical trial management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corgenix company profile →
Resolian
HQ: United States
Website
- Description: Provider of multinational bioanalytical CRO services focused on medication metabolism and pharmacokinetics for small and big compounds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Resolian company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Adare Pharma Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Adare Pharma Solutions
2.2 - Growth funds investing in similar companies to Adare Pharma Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Adare Pharma Solutions
4.2 - Public trading comparable groups for Adare Pharma Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →